We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

156 hedge funds and large institutions have $332M invested in Emergent Biosolutions in 2024 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 46 increasing their positions, 36 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

116% more call options, than puts

Call options by funds: $4.86M | Put options by funds: $2.25M

76% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 21

28% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 36

26% more capital invested

Capital invested by funds: $265M → $332M (+$67.6M)

11% more funds holding

Funds holding: 140 → 156 (+16)

5.47% more ownership

Funds ownership: 58.66% → 64.13% (+5.5%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
156
Holders Change
+16
Holders Change %
+11.43%
% of All Funds
2.05%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
37
Increased
46
Reduced
36
Closed
21
Calls
$4.86M
Puts
$2.25M
Net Calls
+$2.61M
Net Calls Change
+$3.54M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$6.17M
2
Invesco
Invesco
Georgia
+$5.86M
3
Goldman Sachs
Goldman Sachs
New York
+$4.78M
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
+$4.38M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.37M

Top Sellers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
-$10.7M
2
Charles Schwab
Charles Schwab
California
-$8.58M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$3.56M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$1.81M
5
KLP
Kent Lake PR
Puerto Rico
-$1.67M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$3.17M +$129K +14,054 +4%
New York State Common Retirement Fund
27
New York State Common Retirement Fund
New York
$2.93M +$827K +90,113 +42%
Federated Hermes
28
Federated Hermes
Pennsylvania
$2.66M +$55.6K +6,058 +2%
Cetera Investment Advisers
29
Cetera Investment Advisers
Illinois
$2.65M -$984K -107,236 -28%
PGCM
30
Prescott Group Capital Management
Oklahoma
$2.01M +$1.38M +150,000 +250%
Acadian Asset Management
31
Acadian Asset Management
Massachusetts
$1.92M +$911K +99,250 +97%
CSS
32
Cubist Systematic Strategies
Connecticut
$1.9M -$1.21M -132,107 -40%
Nomura Holdings
33
Nomura Holdings
Japan
$1.86M -$586K -63,900 -25%
Allspring Global Investments
34
Allspring Global Investments
North Carolina
$1.83M +$1.76M +191,577 New
Jacobs Levy Equity Management
35
Jacobs Levy Equity Management
New Jersey
$1.77M – – –
Jane Street
36
Jane Street
New York
$1.72M +$297K +32,345 +22%
Man Group
37
Man Group
United Kingdom
$1.69M +$1.62M +176,780 New
MAM
38
Morse Asset Management
Connecticut
$1.52M +$1.46M +158,819 New
Fuller & Thaler Asset Management
39
Fuller & Thaler Asset Management
California
$1.49M +$1.56K +170 +0.1%
HH
40
Hilltop Holdings
Texas
$1.48M -$155K -16,891 -10%
Citadel Advisors
41
Citadel Advisors
Florida
$1.44M +$1.2M +130,338 +636%
SSA
42
Schonfeld Strategic Advisors
New York
$1.39M +$1.34M +145,912 New
Northern Trust
43
Northern Trust
Illinois
$1.39M +$33.9K +3,692 +3%
Rafferty Asset Management
44
Rafferty Asset Management
New York
$1.38M +$6.41K +699 +0.5%
JF
45
Jump Financial
Illinois
$1.36M +$959K +104,518 +279%
Fidelity Investments
46
Fidelity Investments
Massachusetts
$1.35M +$113K +12,296 +10%
Deutsche Bank
47
Deutsche Bank
Germany
$1.33M – – –
WAM
48
Wolverine Asset Management
Illinois
$1.3M +$1.25M +136,333 New
Wellington Management Group
49
Wellington Management Group
Massachusetts
$1.29M -$8.69K -947 -0.7%
SFI
50
Susquehanna Fundamental Investments
Pennsylvania
$944K +$906K +98,731 New
1
2
3 4 5

EBS Hedge Fund Activity: Q4 2024 in Review

156 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q4 2024, worth a combined $332M — up 26% from $265M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new EBS positions and 21 closed out — a net gain of 16 holders — while 46 added to existing stakes and 36 trimmed.

The largest buyer was Millennium Management, adding an estimated $6.17M. The largest seller was Marshall Wace, cutting an estimated $10.7M.

  • 156 institutional investors held Emergent Biosolutions (EBS) as of Q4 2024, up from 140 in Q3 2024.
  • Funds reported $332M of Emergent Biosolutions stock for Q4 2024, up 26% quarter-over-quarter.
  • 37 funds opened new Emergent Biosolutions positions in Q4 2024 and 21 closed out, a net change of +16 holders.
  • The largest Emergent Biosolutions buyer in Q4 2024 was Millennium Management, an estimated $6.17M added.
  • The largest Emergent Biosolutions seller in Q4 2024 was Marshall Wace, an estimated $10.7M sold.

Based on aggregated 13F filings for Q4 2024.